Literature DB >> 1933593

Use of non-collagen markers in osteoporosis studies.

M T Parviainen1, A Pirskanen, A Mahonen, E M Alhava, P H Mäenpää.   

Abstract

Clinical and research laboratories routinely measure various hormonal and nonhormonal parameters of calcium and phosphorus metabolism, and markers of bone turnover. Such measurements may help clinical decision-making relating to metabolic bone disease and osteoporosis. Molecular biological and cell-culture techniques are being used in basic biochemical research on bone-cell metabolism. Results may aid understanding of normal and abnormal regulation of the bone-cell metabolism, and thus provide further insights relating to the diagnosis and prevention of osteoporosis.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1933593     DOI： 10.1007/bf02555084

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


  27 in total

1.  Sex- and age-related changes in bone and serum osteocalcin.

Authors:  D Vanderschueren; G Gevers; G Raymaekers; P Devos; J Dequeker
Journal:  Calcif Tissue Int       Date:  1990-03       Impact factor: 4.333

2.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

3.  Ligand-dependent regulation of the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells.

Authors:  L C Pan; P A Price
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

4.  1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line.

Authors:  R T Franceschi; W M James; G Zerlauth
Journal:  J Cell Physiol       Date:  1985-06       Impact factor: 6.384

5.  Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.

Authors:  S Dokoh; C A Donaldson; M R Haussler
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

6.  Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis.

Authors:  J E Zerwekh; K Sakhaee; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

7.  Plasma bone Gla protein concentrations in healthy adults. Dependence on sex, age, and glomerular filtration.

Authors:  J S Johansen; K Thomsen; C Christiansen
Journal:  Scand J Clin Lab Invest       Date:  1987-06       Impact factor: 1.713

8.  1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.

Authors:  R J Duda; R Kumar; K I Nelson; A R Zinsmeister; K G Mann; B L Riggs
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease.

Authors:  R J Duda; J F O'Brien; J A Katzmann; J M Peterson; K G Mann; B L Riggs
Journal:  J Clin Endocrinol Metab       Date:  1988-05       Impact factor: 5.958

10.  Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss.

Authors:  P D Delmas; D Stenner; H W Wahner; K G Mann; B L Riggs
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.